查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2014861

膝關節重組市場：依產品類型、技術、固定方法和最終用戶分類－2026-2032年全球市場預測

Knee Reconstruction Market by Product Type, Technology, Fixation, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，膝關節重組市場價值將達到 32.4 億美元，到 2026 年將成長至 34.6 億美元，到 2032 年將達到 54.9 億美元，複合年成長率為 7.82%。

主要市場統計數據
基準年 2025 32.4億美元
預計年份：2026年 34.6億美元
預測年份 2032 54.9億美元
複合年成長率 (%) 7.82%

透過整合臨床進展、商業性促進因素和不斷發展的醫療保健服務模式，我們正在為下一代膝關節重組奠定基礎。

膝關節重組正處於轉折點，臨床需求、技術創新和醫療保健系統經濟因素在此交匯，重塑醫療設備策略和治療路徑。近年來，植入材料和對位技術的逐步改進，以及術前規劃和術中引導的進步，改變了外科醫生進行初次手術和重新置換手術的方式。同時，保險公司和醫療服務提供者更加重視基於價值的治療結果、縮短住院時間以及向門診治療的轉變，所有這些都影響著醫療設備製造商的採購重點和商業性決策。

機器人技術、向門診治療的轉變以及對實證醫學和供應鏈韌性日益成長的需求，正在推動膝關節重組領域的變革性變化。

在膝關節重組領域，一系列變革正在發生，這些變革正在改變醫療服務的提供方式以及產品的研發和商業化方式。機器人技術和先進的導航系統正從小眾工具發展成為影響植入選擇、手術室工作流程和培訓需求的整合平台。這些技術正擴大與基於雲端的規劃和分析功能相結合，為追蹤治療結果和迭代改進醫療設備創造了新的機會。

2025 年美國關稅措施對採購、供應商合作和臨床供應連續性的累積營運和策略影響。

2025年美國關稅措施起到了催化劑的作用，促使整個膝關節重組生態系統採取了廣泛的營運和戰略應對措施。為了應對目的地體系的變化和進口不確定性的增加，原始設備製造商 (OEM) 和零件供應商正在重新評估其採購地點，優先考慮供應商冗餘，並加快關於近岸外包和產能多元化的討論。這些調整並非僅僅旨在降低成本；它們也體現了縮短前置作業時間、減少跨境物流衝擊風險以及簡化與生產基地相關的監管流程的意圖。

透過對技術、最終用戶、產品類型和固定方法的詳細細分洞察，指導優先順序和臨床引入策略。

精細的市場細分觀點揭示了臨床實踐、技術和購買行為的交匯點，並著重闡述了這些因素如何共同構成機會和風險。基於技術，市場研究將其分為四種模式：電腦輔助導航、傳統手動方法、患者客製化器材和機器人輔助。每種模式都對臨床工作流程和培訓產生獨特的影響。電腦輔助導航往往更受那些希望在不徹底改造手術室的情況下逐步提升手術精準度的醫療機構的青睞；而機器人輔助系統則重新定義了資本投資決策，並將一個全面的數位生態系統擴展到單次手術之外。患者特異性器械為將術前影像整合到簡化的植入選擇流程中提供了契機；而在成本控制和外科醫生熟悉度至關重要的情況下，傳統手動方法仍然不可或缺。

世界各地在實施、償還和基礎設施發展方面的關鍵區域觀點，正在塑造不同的商業化方法。

區域趨勢在塑造膝關節重組技術的普及曲線和商業化策略方面發揮著至關重要的作用。在美洲，完善的醫院網路和不斷擴大的門診手術中心容量，催生了對先進導航技術和支援門診手術過渡的簡化植入的需求。該地區的健保報銷體係日益注重效率和術後恢復，推動了對能夠改善復健指標的設備和數位平台的投資。同時，都市區三級醫療機構和區域醫院在臨床實踐方面的差異，使得針對不同病例複雜程度，需要製定個人化的外科醫生參與計劃和循證方案。

這提供了企業級的策略洞察，揭示了領先的整形外科公司如何將平台創新、臨床證據和適應性經營模式相結合，以實現市場推廣。

膝關節重組領域的主要企業正在推行多管齊下的策略，將技術投資、臨床證據的累積以及產品上市時間的創新相結合。一些企業專注於平台策略，整合機器人技術、術前規劃軟體和結果分析，透過耗材和服務的整合交付，與醫療系統建立長期合作關係。另一些企業則優先開發模組化植入組合，以填補特定的臨床空白，例如保留骨骼的部分置換術和可降低術中複雜性的可靠重新置換系統。同時，製造商也在投資外科培訓學院和導師制項目，以加速安全部署，並累積臨床案例，從而支持產品在醫院和門診環境中的廣泛應用。

為醫療設備製造商、醫療保健系統和經銷商提供切實可行的策略和營運建議，以加快部署速度並增強韌性。

產業領導者應採取一系列切實可行的步驟，將策略意圖轉化為臨床、營運和商業領域的可衡量進展。首先，透過投資於能夠減少適應性差異、加速患者康復並顯著改善患者報告結果的產品和數位化工具，使研發重點與可證實的臨床價值保持一致。其次，建構以外科醫生為中心的教育項目，結合模擬、指導和結果回饋，以加速安全應用，同時降低阻礙應用的學習曲線成本。

一套嚴謹的調查方法，說明一手訪談、二手文獻整合和資料檢驗驗證，旨在為決策者提供可靠且可操作的見解。

本研究採用結構化調查方法，結合一手訪談、二手文獻整合和系統性資料檢驗，以確保其可靠性和對決策者的相關性。一手資料包括對骨科醫生、醫院採購經理、門診手術中心管理人員和供應鏈主管的結構化訪談，旨在收集關於技術採納、臨床工作流程和採購標準的第一手觀點。除這些定性見解外，本研究還對同行評審的臨床文獻、監管指導文件和公開的醫療保健系統採購協議進行了二手分析，以闡明實踐模式和證據閾值。

為了引領膝關節重組領域，相關人員應協調臨床卓越性、營運韌性和實證商業化。

總而言之，膝關節重組正因技術創新、醫療服務模式的變革以及人們對療效價值日益成長的期望而轉變。機器人手術、導航技術和個人化患者規劃正從實驗階段走向主流，成為許多高水準醫療機構的常規選擇。然而，成功的商業化需要將循證醫學證據的產生、外科醫生的培訓以及營運準備與醫院和門診的實際採購行為相協調。 2025年費用上漲的壓力正在加速供應鏈重組，並重新激發人們對本地採購的興趣，但區域趨勢仍影響著跨區域技術應用的速度和方式。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：膝關節重組市場：依產品類型分類

  • 部分膝關節關節重建手術
  • 膝蓋大腿關節重建
  • 重新置換關節重建手術
  • 全膝關節置換術

第9章：膝關節重組市場：依技術分類

  • 電腦輔助導航
  • 傳統手工方法
  • 患者專用設備
  • 機器人支援

第10章：以固定方式分類的膝關節重組市場

  • 水泥固定型
  • 無水泥
  • 混合

第11章：膝關節重組市場：依最終用戶分類

  • 門診手術中心
  • 醫院

第12章：膝關節重組市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：膝關節重組市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 膝關節重組市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國膝關節重組市場

第16章：中國膝關節重組市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Arthrex, Inc.
  • B. Braun Melsungen AG
  • ConforMIS, Inc.
  • Corin Group Limited
  • DePuy Synthes, Inc.
  • Exactech, Inc.
  • MicroPort Scientific Corporation
  • Smith & Nephew plc
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-43470FC60848

The Knee Reconstruction Market was valued at USD 3.24 billion in 2025 and is projected to grow to USD 3.46 billion in 2026, with a CAGR of 7.82%, reaching USD 5.49 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.24 billion
Estimated Year [2026] USD 3.46 billion
Forecast Year [2032] USD 5.49 billion
CAGR (%) 7.82%

Setting the stage for next-generation knee reconstruction with a clear synthesis of clinical advances, commercial drivers, and evolving care delivery models

Knee reconstruction is at an inflection point where clinical needs, technological innovation, and health system economics converge to reshape device strategy and care pathways. Over recent years, incremental improvements in implant materials and alignment techniques have combined with advances in preoperative planning and intraoperative guidance to alter how surgeons approach primary and revision procedures. Simultaneously, payers and providers have emphasized value-based outcomes, shorter lengths of stay, and the migration of procedures to ambulatory settings, all of which influence procurement priorities and the commercial calculus for device manufacturers.

Against this backdrop, stakeholders require a holistic view that connects device-level innovation with changes in clinical workflow, reimbursement models, and distribution dynamics. Integrating evidence generation, surgeon training programs, and digital tools for implant selection is now a core competency for market participants. With rising attention on patient-reported outcomes and cost-effectiveness, strategic decisions about technology investments and partnership models must be grounded in multidisciplinary insights. Accordingly, this introduction frames the clinical, technological, and commercial drivers that will inform subsequent sections and guides readers toward actionable conclusions that support sustainable growth and improved patient care.

Transformative shifts in knee reconstruction driven by robotics, care migration to ambulatory settings, and heightened demands for evidence and supply chain resilience

The landscape for knee reconstruction is undergoing a set of transformative shifts that are changing how care is delivered and how products are developed and commercialized. Robotics and advanced navigation systems are maturing from niche tools into integrated platforms that influence implant choice, operating room workflows, and training requirements. These technologies are increasingly paired with cloud-based planning and analytics, which create new opportunities for outcome tracking and iterative device improvement.

Concurrently, the shifting locus of care toward ambulatory surgical centers and same-day discharge pathways is prompting manufacturers and health systems to redesign implants and instrumentation for efficiency, sterility management, and rapid turnover. Value-based contracting and outcome-linked procurement place a premium on long-term survivorship data and patient-reported outcomes, which in turn drives investment in registries and post-market evidence generation. In addition, supply chain resilience and regional sourcing strategies are rising on executive agendas, spurred by recent disruptions that highlighted dependency risks. Taken together, these shifts require an adaptive approach: companies that align clinical evidence, surgeon engagement, and operational efficiencies will be best positioned to capture adoption waves and sustain competitive advantage.

Cumulative operational and strategic consequences of 2025 United States tariff measures on sourcing, supplier collaboration, and clinical supply continuity

United States tariff activity in 2025 has functioned as a catalyst for a range of operational and strategic responses across the knee reconstruction ecosystem. In response to altered duty regimes and elevated import unpredictability, original equipment manufacturers and component suppliers have reassessed sourcing footprints, prioritized supplier redundancy, and accelerated conversations about nearshoring and capacity diversification. These adjustments are not solely cost-driven; they also reflect a desire to shorten lead times, reduce exposure to cross-border logistical shocks, and simplify regulatory pathways tied to production locales.

Consequently, procurement teams and device developers have adopted more granular vendor risk assessments and increased emphasis on long-term supplier partnerships that include shared business continuity planning. For hospital systems and ambulatory surgical centers, procurement strategies have shifted toward multi-vendor approaches and increased scrutiny of total landed cost rather than unit price alone, integrating considerations such as inventory buffering, consignment arrangements, and collaboration on demand forecasting. Regulatory compliance and customs documentation have become higher touchpoints in supplier relationships, prompting organizations to invest in trade-compliance capabilities and specialist legal support.

As a result of these pressures, alliances between manufacturers and local contract manufacturers or component partners have become more common, enabling faster responses to demand fluctuations and closer integration of quality management systems. In sum, the cumulative tariff environment in 2025 has accelerated structural changes in sourcing, inventory management, and supplier collaboration that will shape commercial strategies and operational readiness in the near term.

Deep segmentation insights across technology, end user, product type, and fixation approaches to guide prioritization and clinical adoption strategies

A nuanced segmentation view illuminates where clinical practice, technology, and purchasing behavior intersect to shape opportunity and risk. Based on Technology, market is studied across Computer Assisted Navigation, Conventional Manual, Patient Specific Instrumentation, and Robotics Assisted, and each modality presents distinct clinical workflows and training implications. Computer assisted navigation often appeals to centers seeking incremental improvements in alignment without retooling the entire operating room, whereas robotics assisted systems redefine capital investment decisions and bring comprehensive digital ecosystems that extend beyond the single procedure. Patient specific instrumentation creates opportunities to integrate preoperative imaging into a streamlined implant selection pathway, and conventional manual approaches retain relevance where cost containment and surgeon familiarity predominate.

Based on End User, market is studied across Ambulatory Surgical Centers and Hospitals, and this segmentation underscores divergent purchasing cycles, clinical throughput expectations, and sterilization and inventory needs. Hospitals typically manage complex case mixes and prioritize implants that perform across a range of indications, while ambulatory surgical centers seek solutions that optimize turnaround time and enable efficient, high-volume throughput. Based on Product Type, market is studied across Partial Knee Replacement, Patellofemoral Arthroplasty, Revision Knee Replacement, and Total Knee Replacement, which highlights product development pathways: partial and patellofemoral solutions emphasize bone preservation and faster recovery, total knee replacements address broad degenerative disease, and revision systems focus on modularity and complex fixation. Based on Fixation, market is studied across Cemented, Cementless, and Hybrid approaches, each representing different surgeon preferences, patient bone quality considerations, and long-term outcome trade-offs. Collectively, these segmentation lenses guide prioritization of R&D investments, surgeon education strategies, and tailored commercial models for diverse end users and clinical scenarios.

Critical regional perspectives on adoption, reimbursement, and infrastructure readiness shaping differentiated commercialization approaches across global territories

Regional dynamics play a pivotal role in shaping the adoption curve and commercialization strategies for knee reconstruction technologies. In the Americas, strong hospital networks and growing ambulatory surgical center capacity create demand for both advanced navigation and streamlined implants that support outpatient conversion. Reimbursement frameworks in this region increasingly reward efficiency and post-acute outcomes, encouraging investment in devices and digital platforms that demonstrate improved recovery metrics. Meanwhile, clinical practice variability between urban tertiary centers and community hospitals requires tailored surgeon engagement plans and evidence packages that address different caseload complexities.

In Europe, Middle East & Africa, heterogeneous regulatory landscapes and diverse reimbursement environments create an environment where localized go-to-market models are essential. Some countries within the region adopt fast-track pathways for innovative devices, while others emphasize cost containment, requiring flexible pricing and value demonstration. Infrastructure differences across the region also influence adoption timing for robotics and navigation systems, with higher-density tertiary networks piloting advanced platforms that later diffuse into broader hospital systems.

In Asia-Pacific, rapid investment in surgical capacity, expanding middle-class demand for elective orthopedic care, and government-led hospital expansions are driving interest in scalable instrumentation and digital planning tools. Local manufacturing capability and strategic partnerships with regional distributors often accelerate access, while divergent surgeon training needs and procedural volumes demand robust education models. Across all regions, regulatory agility, reimbursement alignment, and distribution excellence remain critical determinants of successful commercialization, and companies that adapt their value propositions to regional priorities will gain traction more quickly.

Strategic company-level insights revealing how leading orthopedic firms combine platform innovation, clinical evidence, and adaptive commercial models to win adoption

Leading companies in the knee reconstruction space are pursuing multifaceted strategies that combine technological investment, clinical evidence generation, and go-to-market innovation. Some organizations are concentrating on platform plays that bundle robotics, preoperative planning software, and outcome analytics, enabling longer-term relationships with health systems through integrated consumable and service offerings. Others prioritize modular implant portfolios that target specific clinical gaps, such as bone-preserving partial replacements or robust revision systems that reduce intraoperative complexity. In parallel, manufacturers are investing in surgeon training academies and proctorship programs to accelerate safe adoption and to generate the clinical narratives that support uptake in both hospitals and ambulatory settings.

Commercially, companies are experimenting with alternative contracting models that align pricing with outcomes or that facilitate capital access for robotics through lease and subscription arrangements. Supply chain strategies increasingly emphasize dual-sourcing, localized manufacturing partnerships, and enhanced inventory transparency to reduce disruption risk. In regulatory and reimbursement arenas, industry participants are accelerating post-market evidence collection and registry participation to demonstrate comparative effectiveness across fixation approaches and product types. Where companies have differentiated, they typically combine clinical partnerships, rigorous outcomes tracking, and flexible commercial models to lower adoption friction and to strengthen customer retention in a rapidly evolving marketplace.

Actionable strategic and operational recommendations for device makers, health systems, and distributors to accelerate adoption while strengthening resilience

Industry leaders should adopt a set of pragmatic actions that translate strategic intent into measurable progress across clinical, operational, and commercial domains. First, align R&D priorities with demonstrable clinical value by investing in products and digital tools that reduce variability in alignment, enhance patient recovery, and enable measurable improvements in patient-reported outcomes. Second, build surgeon-centric education programs that combine simulation, proctoring, and outcomes feedback to accelerate safe adoption while reducing the learning curve costs that inhibit uptake.

Third, reconfigure supply chain and sourcing strategies to prioritize resilience and flexibility: establish alternative suppliers for critical components, explore regional manufacturing partnerships, and implement inventory strategies that smooth demand volatility. Fourth, pursue commercial models that lower adoption barriers for capital-intensive technologies through leasing, bundled services, or outcome-linked contracting, and coordinate these offers with payer-engagement plans that articulate value across the episode of care. Fifth, scale evidence generation by committing to registry participation and structured post-market studies that capture long-term outcomes across fixation types and product variants, because robust data will be decisive in procurement discussions. Lastly, incorporate scenario planning into strategic reviews to anticipate tariff and trade-policy shifts, ensuring that go-to-market plans remain executable under multiple regulatory and economic contingencies. Taken together, these actions will position organizations to capture adoption opportunities while maintaining operational and financial stability.

Robust research methodology describing primary interviews, secondary synthesis, and data triangulation to deliver credible and actionable insights for decision-makers

This research draws on a structured methodology combining primary interviews, secondary literature synthesis, and systematic data validation to ensure reliability and relevance for decision-makers. Primary inputs included structured interviews with orthopedic surgeons, hospital procurement leaders, ambulatory surgical center administrators, and supply chain executives to capture firsthand perspectives on technology adoption, clinical workflows, and purchasing criteria. These qualitative insights were supplemented by secondary analysis of peer-reviewed clinical literature, regulatory guidance documents, and publicly available health system procurement protocols to contextualize practice patterns and evidentiary thresholds.

Data triangulation occurred through cross-referencing interview findings with product approval pathways and published clinical outcome studies, enabling identification of consistent themes and areas of divergence. Attention was paid to temporal relevance by prioritizing the most recent clinical trials, registry reports, and guideline updates, and by validating claims with multiple independent sources when feasible. Limitations of the approach include dependent variability in regional data transparency and evolving policy environments that can change operational assumptions; consequently, scenario-based sensitivity checks and expert workshops were used to interrogate critical uncertainties. Finally, methodological rigor was maintained through internal peer review and iterative refinement of conclusions to ensure actionable and defensible recommendations for industry stakeholders.

Concluding imperatives for stakeholders to align clinical excellence, operational resilience, and evidence-driven commercialization to lead in knee reconstruction

In summary, knee reconstruction is being reshaped by technological innovation, shifting care settings, and heightened expectations for demonstrable value. Robotics, navigation, and patient-specific planning are moving from experimental to mainstream considerations in many high-volume centers, but successful commercialization depends on aligning evidence generation, surgeon training, and operational readiness with the realities of hospital and ambulatory purchasing behaviors. Tariff-related pressures in 2025 have accelerated supply chain reconfiguration and renewed focus on regional sourcing, while regional dynamics continue to dictate the pace and nature of technology uptake across geographies.

Looking ahead, the industry will reward participants who integrate clinical excellence with adaptable commercial models and resilient supply chains. Stakeholders that invest in robust post-market evidence, design pragmatic surgeon education programs, and structure flexible contracting options will reduce adoption friction and create durable value propositions for providers and patients. In closing, strategic clarity, operational discipline, and sustained clinical partnership are the critical levers that will determine which organizations lead the next wave of innovation in knee reconstruction.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Knee Reconstruction Market, by Product Type

  • 8.1. Partial Knee Replacement
  • 8.2. Patellofemoral Arthroplasty
  • 8.3. Revision Knee Replacement
  • 8.4. Total Knee Replacement

9. Knee Reconstruction Market, by Technology

  • 9.1. Computer Assisted Navigation
  • 9.2. Conventional Manual
  • 9.3. Patient Specific Instrumentation
  • 9.4. Robotics Assisted

10. Knee Reconstruction Market, by Fixation

  • 10.1. Cemented
  • 10.2. Cementless
  • 10.3. Hybrid

11. Knee Reconstruction Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Hospitals

12. Knee Reconstruction Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Knee Reconstruction Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Knee Reconstruction Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Knee Reconstruction Market

16. China Knee Reconstruction Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Arthrex, Inc.
  • 17.6. B. Braun Melsungen AG
  • 17.7. ConforMIS, Inc.
  • 17.8. Corin Group Limited
  • 17.9. DePuy Synthes, Inc.
  • 17.10. Exactech, Inc.
  • 17.11. MicroPort Scientific Corporation
  • 17.12. Smith & Nephew plc
  • 17.13. Stryker Corporation
  • 17.14. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL KNEE RECONSTRUCTION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL KNEE RECONSTRUCTION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES KNEE RECONSTRUCTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA KNEE RECONSTRUCTION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PARTIAL KNEE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PATELLOFEMORAL ARTHROPLASTY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PATELLOFEMORAL ARTHROPLASTY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PATELLOFEMORAL ARTHROPLASTY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY REVISION KNEE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY REVISION KNEE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY REVISION KNEE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY TOTAL KNEE REPLACEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY COMPUTER ASSISTED NAVIGATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY COMPUTER ASSISTED NAVIGATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY COMPUTER ASSISTED NAVIGATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CONVENTIONAL MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CONVENTIONAL MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CONVENTIONAL MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PATIENT SPECIFIC INSTRUMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PATIENT SPECIFIC INSTRUMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY PATIENT SPECIFIC INSTRUMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY ROBOTICS ASSISTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY ROBOTICS ASSISTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY ROBOTICS ASSISTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CEMENTED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CEMENTED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CEMENTED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CEMENTLESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CEMENTLESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY CEMENTLESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. AMERICAS KNEE RECONSTRUCTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 47. AMERICAS KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 48. AMERICAS KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 49. AMERICAS KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 50. AMERICAS KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. NORTH AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. NORTH AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. NORTH AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 54. NORTH AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 55. NORTH AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 56. LATIN AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. LATIN AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 58. LATIN AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 59. LATIN AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 60. LATIN AMERICA KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 63. EUROPE, MIDDLE EAST & AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 64. EUROPE, MIDDLE EAST & AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 65. EUROPE, MIDDLE EAST & AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. EUROPE KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. EUROPE KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 68. EUROPE KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 69. EUROPE KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 70. EUROPE KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 71. MIDDLE EAST KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. MIDDLE EAST KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 73. MIDDLE EAST KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 74. MIDDLE EAST KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 75. MIDDLE EAST KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 76. AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 78. AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 79. AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 80. AFRICA KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. ASEAN KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. ASEAN KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. ASEAN KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 90. ASEAN KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 91. ASEAN KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. GCC KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GCC KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. GCC KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 95. GCC KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 96. GCC KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPEAN UNION KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPEAN UNION KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPEAN UNION KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPEAN UNION KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPEAN UNION KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. BRICS KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. BRICS KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. BRICS KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 105. BRICS KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 106. BRICS KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 107. G7 KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. G7 KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. G7 KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 110. G7 KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 111. G7 KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. NATO KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. NATO KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. NATO KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 115. NATO KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 116. NATO KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL KNEE RECONSTRUCTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. UNITED STATES KNEE RECONSTRUCTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 119. UNITED STATES KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 120. UNITED STATES KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 121. UNITED STATES KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 122. UNITED STATES KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. CHINA KNEE RECONSTRUCTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. CHINA KNEE RECONSTRUCTION MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. CHINA KNEE RECONSTRUCTION MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 126. CHINA KNEE RECONSTRUCTION MARKET SIZE, BY FIXATION, 2018-2032 (USD MILLION)
  • TABLE 127. CHINA KNEE RECONSTRUCTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)